HK1256876A1 - 促進有益微生物群生長的益生菌和人乳寡糖的合益素組合 - Google Patents

促進有益微生物群生長的益生菌和人乳寡糖的合益素組合

Info

Publication number
HK1256876A1
HK1256876A1 HK18115976.6A HK18115976A HK1256876A1 HK 1256876 A1 HK1256876 A1 HK 1256876A1 HK 18115976 A HK18115976 A HK 18115976A HK 1256876 A1 HK1256876 A1 HK 1256876A1
Authority
HK
Hong Kong
Prior art keywords
probiotic
human milk
promote growth
milk oligosaccharides
beneficial microbiota
Prior art date
Application number
HK18115976.6A
Other languages
English (en)
Inventor
Jomay Chow
Rachael Buck
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HK1256876A1 publication Critical patent/HK1256876A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK18115976.6A 2010-12-31 2018-12-12 促進有益微生物群生長的益生菌和人乳寡糖的合益素組合 HK1256876A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201061428869P 2010-12-31 2010-12-31

Publications (1)

Publication Number Publication Date
HK1256876A1 true HK1256876A1 (zh) 2019-10-04

Family

ID=45529204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115976.6A HK1256876A1 (zh) 2010-12-31 2018-12-12 促進有益微生物群生長的益生菌和人乳寡糖的合益素組合

Country Status (11)

Country Link
US (1) US20120171166A1 (zh)
EP (2) EP3335577A1 (zh)
CN (1) CN103763940B (zh)
BR (1) BR112013016914A2 (zh)
CA (1) CA2822660C (zh)
HK (1) HK1256876A1 (zh)
MX (1) MX356184B (zh)
NZ (1) NZ612386A (zh)
SG (1) SG191798A1 (zh)
TW (1) TW201304692A (zh)
WO (1) WO2012092155A1 (zh)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2498628B1 (en) 2010-12-29 2014-04-30 Abbott Laboratories Products for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
EP2658549B1 (en) 2010-12-31 2020-06-03 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CA2822500C (en) * 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
SG192095A1 (en) * 2011-02-10 2013-08-30 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
BR112014004772A2 (pt) * 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
EP3704957A1 (en) * 2012-09-14 2020-09-09 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2014110685A1 (en) 2013-01-21 2014-07-24 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
MX2015011771A (es) 2013-03-08 2016-12-07 Axiom Foods Inc Suplemento de proteínas de arroz y métodos de uso de este.
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
CN105899089A (zh) * 2013-12-19 2016-08-24 雀巢产品技术援助有限公司 用于减少婴儿代谢应激、降低肠道通透性和接近母乳喂养婴儿的生长速度的营养组合物
EP3673909A1 (en) 2014-04-08 2020-07-01 Abbott Laboratories Nutritional compositions for use in treating enteric infection comprising human milk oligosaccharides
EP3209308B1 (en) * 2014-10-24 2022-08-03 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212198B1 (en) * 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
CN115350200A (zh) * 2014-12-08 2022-11-18 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
CN104528149A (zh) * 2014-12-31 2015-04-22 福建美力生生物科技股份有限公司 一种即用型益生菌饮料产品
BR112017014192B1 (pt) * 2015-01-14 2022-02-01 Infant Bacterial Therapeutics Ab Preparação
EP3264920B1 (en) * 2015-03-05 2020-12-16 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
CN107920579A (zh) 2015-08-04 2018-04-17 雀巢产品技术援助有限公司 用于诱导与母乳喂养的婴幼儿的肠道微生物群接近的肠道微生物群的包含动物双歧杆菌乳酸亚种（Bifidobacterium animalis ssp.lactis）以及任选的低聚糖的混合物的营养组合物和婴儿配方食品
WO2017021476A1 (en) 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
US10751354B2 (en) * 2015-09-14 2020-08-25 Glycom A/S Synthetic composition for microbiota modulation
EP3368047B1 (en) 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
EP3407739B1 (en) * 2016-01-26 2021-06-23 Société des Produits Nestlé S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
AU2017211272B2 (en) * 2016-01-26 2022-04-21 Société des Produits Nestlé S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
EP3407738B1 (en) * 2016-01-26 2022-02-09 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
WO2017129646A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
CN108495562A (zh) 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 具有特异性低聚糖的用于预防或治疗变态反应的组合物
AU2017230187A1 (en) * 2016-03-11 2018-10-04 Infinant Health, Inc A transient commensal microorganism for improving gut health
WO2017190754A1 (en) * 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
US11224605B2 (en) * 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
WO2018006080A1 (en) 2016-07-01 2018-01-04 Evolve Biosystems Inc. Method for facilitating maturation of the mammalian immune system
EP3493686B1 (en) * 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
US20180064739A1 (en) * 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
US10993970B2 (en) 2016-12-19 2021-05-04 Hany Z. ALY Medical-grade honey for growth enhancement of infants
MX2019011446A (es) * 2017-05-09 2019-11-18 Nestle Sa Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños con fines de salud.
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
CN110573030A (zh) * 2017-05-24 2019-12-13 雀巢产品有限公司 用于增强注意力和/或降低冲动的营养组合物
US11541069B2 (en) * 2017-11-02 2023-01-03 Glycom A/S One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
JP7327724B2 (ja) * 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのｈｍｏの混合物
WO2019106147A1 (en) * 2017-12-01 2019-06-06 Nestec S.A. Human milk fortifier composition
KR20200096793A (ko) * 2017-12-08 2020-08-13 젠와인 바이오테크놀로지 게엠바하 분무건조된 사당류
BR112020008724A2 (pt) * 2017-12-21 2020-11-03 Société des Produits Nestlé S.A. composições para uso na promoção do crescimento e desenvolvimento do músculo intestinal e motilidade intestinal associada
EP3782480A4 (en) * 2018-03-29 2022-01-12 Morinaga Milk Industry Co., Ltd. NUTRITIONAL COMPOSITION, FOOD/BEVERAGE COMPOSITION USING THE NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING THE NUTRITIONAL COMPOSITION
EP3583858A1 (en) * 2018-06-20 2019-12-25 DuPont Nutrition Biosciences ApS Compositions for treating or preventing gut barrier dysfunction
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
WO2019232284A1 (en) * 2018-05-30 2019-12-05 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN113163836A (zh) * 2018-06-01 2021-07-23 进化生物系统股份有限公司 促进宿主防御和刺激、扩增和/或重置t细胞库的组合物和方法
WO2020001863A1 (en) * 2018-06-25 2020-01-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
CN112423603A (zh) * 2018-07-12 2021-02-26 N·V·努特里奇亚 用于改善肠屏障完整性的营养组合物、组合物的制备以及治疗方法
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
WO2020126542A1 (en) * 2018-12-21 2020-06-25 Societe Des Produits Nestle S.A. A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
US20220160013A1 (en) * 2019-03-05 2022-05-26 Glycom A/S Human milk oligosaccharides for use in enhancing executive function
EP3934656A1 (en) * 2019-03-05 2022-01-12 Société des Produits Nestlé S.A. A nutritional composition for use to enhance executive function
BR112021024149A2 (pt) * 2019-06-05 2022-02-08 Glycom As Oligossacarídeos de leite humano para uso no tratamento de sintomas em um paciente sofrendo de sensibilidade não celíaca ao trigo e/ou glúten
CA3158836A1 (en) * 2019-11-20 2021-05-27 Abbott Laboratories Nutritional compositions for treating a clostridium difficile infection
CN118020940A (zh) * 2019-11-29 2024-05-14 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
AU2020419435A1 (en) * 2019-12-30 2022-05-26 Société des Produits Nestlé S.A. Infant formula
JP7474596B2 (ja) 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
JP2021112165A (ja) * 2020-01-20 2021-08-05 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
CN116347997A (zh) * 2020-11-10 2023-06-27 雀巢产品有限公司 营养组合物
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
US20230413887A1 (en) * 2020-12-01 2023-12-28 Frieslandcampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
WO2022155201A1 (en) * 2021-01-12 2022-07-21 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用
CN114223728B (zh) * 2021-11-30 2024-03-26 内蒙古伊利实业集团股份有限公司 含有益生元与益生菌的早产/低出生体重婴儿配方奶粉

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036745A2 (en) 1997-02-21 1998-08-27 Abbot Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
EP1255449B2 (en) * 2000-02-17 2016-06-08 Nestec S.A. Nutritional formulation containing prebiotic substances
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
MY149913A (en) * 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
PT1993577E (pt) * 2006-03-10 2014-05-27 Nutricia Nv Uso de sacarídeos não digestivos para proporcionar a uma criança o melhor começo após o nascimento
US20070255598A1 (en) * 2006-03-29 2007-11-01 Mccarthy Nancy J Compliance aid, kits comprising the compliance aid, and methods of use
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2127661A1 (en) * 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
BR112012017978A2 (pt) * 2010-01-19 2016-05-03 Abbott Lab fórmulas nutricionais contendo simbióticos

Also Published As

Publication number Publication date
MX2013007675A (es) 2013-07-29
EP2658402A1 (en) 2013-11-06
EP3335577A1 (en) 2018-06-20
CA2822660A1 (en) 2012-07-05
CA2822660C (en) 2021-09-07
US20120171166A1 (en) 2012-07-05
NZ612386A (en) 2015-02-27
CN103763940A (zh) 2014-04-30
CN103763940B (zh) 2015-10-14
WO2012092155A1 (en) 2012-07-05
TW201304692A (zh) 2013-02-01
SG191798A1 (en) 2013-08-30
MX356184B (es) 2018-05-17
BR112013016914A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
HK1256876A1 (zh) 促進有益微生物群生長的益生菌和人乳寡糖的合益素組合
HK1255687A1 (zh) 促進有益細菌生長的人乳低聚糖
IL294095A (en) Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
EP2675899A4 (en) BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN MANIPULATED BACTERIA
ZA201306751B (en) Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
PL2748123T3 (pl) Zastosowanie lipochito-oligosacharydów i/lub chito-oligosacharydów w kombinacji z mikroorganizmami solubilizującymi fosforany do poprawy wzrostu roślin
PL2577318T3 (pl) Sposób różnicowania ludzkich embrionalnych komórek macierzystych do nocyceptorów i ich zastosowania
HK1198625A1 (zh) 植入物以及使用其填充骨組織中孔的方法
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2416790A4 (en) SPRAY-DRYED BLOOD PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF
PL2563166T3 (pl) Stosowanie oligosacharydów mleka ludzkiego w żywieniu niemowląt
EP2563372A4 (en) PREBIOTIC FORMULATIONS AND METHODS OF USE
HK1187345A1 (zh) 雜芳基磺酰胺類衍生物，其製備及其在人類治療中的應用
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
IL220715A0 (en) Nutritive compositions and methods of using same
PL2707010T3 (pl) Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii
EP2552226A4 (en) PRODUCTION OF COMPOSITIONS BASED ON CONCENTRATED MILK FAT AND HIGH UNIT DENSITY COMPOSITIONS
PL2547214T3 (pl) Suszony fermentowany produkt mleczny zawierający dużą gęstość żywych bifidobakterii
GB201118001D0 (en) Complete supplement forulae for maintenance of hair growth and condition
HK1173182A1 (zh) 乳杆菌屬乳酸菌的增殖促進劑和/或存活性提高劑
HK1201030A1 (zh) 含有塔格糖和益生乳酸菌的合益素食品組合物
SG10201505145VA (en) Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation
GB2483313B (en) Use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis